- CA$205.37m
- CA$230.43m
- $67.23m
- 76
- 21
- 50
- 47
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 33.45 | ||
| PEG Ratio (f) | 0.51 | ||
| EPS Growth (f) | 185.46% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.31 | ||
| Price to Tang. Book | 31.29 | ||
| Price to Free Cashflow | 573.08 | ||
| Price to Sales | 2.22 | ||
| EV to EBITDA | 30.26 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 0.3% | ||
| Return on Equity | -1% | ||
| Operating Margin | 0.41% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 35.36 | 39.78 | 52.35 | 58.18 | 67.23 | 79.46 | 87.35 | 18.14% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -65.44 | -16.77 | +135.83 | +17.57 | -82.3 | +662.46 | +42.31 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Hamilton Thorne Ltd. is a provider of precision instruments, consumables, software and services to assisted reproductive technologies (ART), research, and cell biology markets. The Company markets its products and services under the Hamilton Thorne, Gynemed, Planer, Tek-Event, IVFtech, Microptic, and Embryotech Laboratories brands. It also provides an array of third-party equipment and consumables to meet customer requirements. Its branded instrument, equipment and software product lines include precision laser devices, imaging systems, incubators, laminar flow workstations, air purification systems, control rate freezers, lab monitoring systems, and micromanipulation systems. It also offers a portfolio of artificial intelligence (AI)-enabled common astronomy software applications (CASA) software and other product offerings. Its GM501 family of products provides the in vitro fertilization (IVF) lab with comprehensive cell culture media solutions.
Directors
- David Wolf CHM
- Michael Bruns CFO
- Fabian Sell CEX
- Diarmaid Douglas-Hamilton SVP
- Robert Potter LED
- David Sable DRC
- Karen Firestone IND (65)
- Feng Han IND
- Bruno Maruzzo IND (63)
- Marc Robinson IND
- Daniel Thorne IND (59)
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- February 19th, 2007
- Public Since
- July 10th, 2007
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
Toronto Stock Exchange- Shares in Issue
- 152,124,765
- Address
- 100 Cummings Ctr Ste 465e, BEVERLY, 01915-6143
- Web
- https://www.hamiltonthorne.com/
- Phone
- +1 9789212050
- Auditors
- MNP LLP
Upcoming Events for HTL
Hamilton Thorne Ltd Annual Shareholders Meeting
Hamilton Thorne Ltd Extraordinary Shareholders Meeting
Hamilton Thorne Ltd Annual Shareholders Meeting
Q2 2024 Hamilton Thorne Ltd Earnings Release
Similar to HTL
Bausch + Lomb
Toronto Stock Exchange
Profound Medical
Toronto Stock Exchange
Sernova
Toronto Stock Exchange
Titan Medical
Toronto Stock Exchange
Vitalhub
Toronto Stock Exchange
FAQ
What is the Hamilton Thorne share price?
As of Today at 19:10 UTC, shares in Hamilton Thorne are trading at CA$1.35. This share price information is delayed by 15 minutes.
How has the Hamilton Thorne share price performed this year?
Shares in Hamilton Thorne last closed at CA$1.35 and the price had moved by -15.63% over the past 365 days. In terms of relative price strength the Hamilton Thorne share price has underperformed the Toronto Stock Exchange 300 Composite Index by -19.94% over the past year.
What are the analyst and broker recommendations for Hamilton Thorne?
The overall consensus recommendation for Hamilton Thorne is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Hamilton Thorne dividend yield?
Hamilton Thorne does not currently pay a dividend.
Does Hamilton Thorne pay a dividend?
Hamilton Thorne does not currently pay a dividend.
When does Hamilton Thorne next pay dividends?
Hamilton Thorne does not currently pay a dividend.
How do I buy Hamilton Thorne shares?
To buy shares in Hamilton Thorne you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Hamilton Thorne?
As of the previous close price of CA$1.35, shares in Hamilton Thorne had a market capitalisation of CA$205.37m.
Where are Hamilton Thorne shares listed?
Here are the trading details for Hamilton Thorne:
- Country of listing: Canada
- Exchange: TOR
- Ticker Symbol: HTL
What kind of share is Hamilton Thorne?
Based on an overall assessment of its quality, value and momentum Hamilton Thorne is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Hamilton Thorne share price forecast for 2024?
The analyst consensus target price for shares in Hamilton Thorne is CA$2.24. That is 66.05% above the last closing price of CA$1.35.
Analysts covering Hamilton Thorne currently have a consensus Earnings Per Share (EPS) forecast of $0.03 for the next financial year.
What is the trend in the Hamilton Thorne share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Hamilton Thorne. Over the past six months, its share price has underperformed the Toronto Stock Exchange 300 Composite Index by -20.33%.
As of the last closing price of CA$1.35, shares in Hamilton Thorne were trading -0.22% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Hamilton Thorne PE Ratio?
The Hamilton Thorne PE ratio based on its reported earnings over the past 12 months is 33.45. The shares last closed at CA$1.35.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Hamilton Thorne?
Hamilton Thorne's management team is headed by:
- David Wolf - CHM
- Michael Bruns - CFO
- Fabian Sell - CEX
- Diarmaid Douglas-Hamilton - SVP
- Robert Potter - LED
- David Sable - DRC
- Karen Firestone - IND
- Feng Han - IND
- Bruno Maruzzo - IND
- Marc Robinson - IND
- Daniel Thorne - IND